No Data
No Data
Cramer's Week Ahead: Fed Rate Decision, Earnings From Darden and Cracker Barrel
Regeneron, Sanofi Get FDA Approval for Upper Airway Disease Treatment
Regeneron Pharmaceuticals And Sanofi Announce FDA Approval For Dupixent In The U.S. As First And Only Treatment For Adolescents With Chronic Rhinosinusitis With Nasal Polyps
Express News | Dupixent® (Dupilumab) Approved in the U.S. as First and Only Treatment for Adolescents With Chronic Rhinosinusitis With Nasal Polyps (Crswnp)
Kiniksa Draws Buy at Jefferies on Potential Blockbuster Status for Lead Drug
Dupixent (Dupilumab) Approved in the U.S. as First and Only Treatment for Adolescents With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
No Data
No Data